CCND1 and metabolic disease: Compared with the ER22/23EK, 9β and wild-type haplotypes, the Bcl1 and N363S haplotypes were not associated with an increased risk of adrenal suppression or metabolic disorders in patients with COPD exacerbation treated with glucocorticoids.